InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2026-06-22 17:20:07 ET · period of report 2026-06-17 · accession 0001707685-26-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2026-06-22 17:20 2026-06-17 PTCT Utter Christine Marie SVP, CAO M - OptEx $25.69 +19.7K 89.9K +28% +$505.7K
DT 2026-06-22 17:20 2026-06-17 PTCT Utter Christine Marie SVP, CAO S - Sale+OE $75.56 -19.7K 70.2K -22% -$1.49M
DT 2026-06-22 17:20 2026-06-17 PTCT Utter Christine Marie SVP, CAO M - OptEx $0.00 -19.7K 15.3K -56% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-17 M A 19,686 $25.69 89,885 D — — (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026.
2 Common Common Stock 2026-06-17 S D 19,686 $75.56 70,199 D — — (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026.
3 Derivative Stock Option (Right to Buy) 2026-06-17 M D 19,686 $0.00 15,314 D $25.69 · — to 2034-02-14 19,686 Common Stock (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2026. (F2) This option was granted on February 15, 2024, and vests over four years, with 25% of the shares underlying the option vesting on February 15, 2025, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on May 15, 2025.